North Point Portfolio Managers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
HCM
FWCM
MSV
AIM
EB
SC
AP
IWA
MPWT
FFA
North Point Portfolio Managers's ABBV Position: Q3 2026 in Review
North Point Portfolio Managers reduced its AbbVie (ABBV) stake by 1.2% in Q3 2026, selling an estimated $6.92K and leaving 2,296 shares worth $601K. The position accounts for 0.1% of the portfolio, ranked #52.
North Point Portfolio Managers first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $8.58M in Q4 2014. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- North Point Portfolio Managers held 2,296 shares of AbbVie worth $601K as of Q3 2026.
- North Point Portfolio Managers sold 27 AbbVie shares in Q3 2026, an estimated $6.92K.
- AbbVie made up 0.1% of North Point Portfolio Managers's portfolio in Q3 2026, its #52 holding.
- North Point Portfolio Managers first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
- North Point Portfolio Managers's AbbVie position peaked at $8.58M in Q4 2014.
- 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on North Point Portfolio Managers's 13F filing for Q3 2026, filed 7 Oct 2026.